[Immunodeficiency and carcinogenesis in patients with chronic active Epstein-Barr virus infection].
Three adult patients with chronic active Epstein-Barr virus infection (CAEBV) had high anti-EBV-VCA antibody, positive anti-EA, low anti-EBNA and were associated with systemic lymphadenopathies and immunosuppression. The case 1 and 2 had elevated serum immunoglobulin levels, and recurrent infections, and case 3 showed pancytopenia. These 3 cases developed both EBV and latent membrane protein (LMP) positive malignant histiocytosis, EBV positive but LMP negative plasmacytoma, and EBV negative acute myelogeneous leukemia, respectively. It was suggested that CAEBV belonged to high risk groups for the development of malignant neoplasms. Since HLA of the case 1 and his father was identical, we conducted a in vitro cytotoxicity test using EBV transformed autologous B lymphocytes, K562 cells, and Raji cells to clarify the association of immunosuppression and HLA. The case 1 showed a low level of specific cytotoxicity to autologous EBV transformed B cells, while his parents were negative for the specific cytotoxicity. The patient and his parents developed inducible cytotoxicity to all targets after in vitro incubation of peripheral mononuclear cells with recombinant interleukin 2 (rIL-2) for 7 days. The patient and his mother showed lower enhancement of cytotoxicity, while HLA identical father could induce good cytotoxic activity to all targets as well as normal controls, indicating that a low IL-2 induced cytotoxic activity observed in CAEBV was independent of HLA associated immunoregulation at least in the case 1. Further studies are required to clarify the exact mechanisms responsible for the development of CAEBV.
Nagafuchi
S
S
First Department of Internal Medicine, Faculty of Medicine, Kyushu University.
Fujisaki
T
T
Ohshima
K
K
Anzai
K
K
Otsuka
T
T
Kikuchi
H
H
Nasu
M
M
Kikuchi
M
M
Sawae
Y
Y
Niho
Y
Y
D000328:Adult; D002908:Chronic Disease; D005260:Female; D006680:HLA Antigens / Q000032:analysis; D006566:Herpesviridae Infections / Q000150:complications* / Q000276:immunology*; D004854:Herpesvirus 4, Human; D015614:Histiocytosis / Q000209:etiology*; D006801:Humans; D007951:Leukemia, Myeloid / Q000209:etiology*; D008297:Male; D010954:Plasmacytoma / Q000209:etiology*; D014412:Tumor Virus Infections / Q000150:complications* / Q000276:immunology*
D006680:HLA Antigens